Sponsors (27)
The bill increases federal attention, research funding, clinical guidance, and public education for endometriosis—which can improve diagnosis, treatment, and equity—but it also creates data-collection and administrative burdens, privacy risks, and may not deliver immediate clinical or coverage changes for all affected patients.
Women with endometriosis (and people with chronic pelvic pain) gain formal recognition of their condition in federal law, which increases visibility, may reduce stigma, and supports stronger public and clinical focus on diagnosis and care.
Patients and researchers receive sustained federal research and surveillance funding (authorized ~$50M/year FY2026–2030) to improve understanding, treatments, and long-term tracking of endometriosis.
Clinicians will get evidence-based guidance on detection, diagnosis, and management, which should improve earlier diagnosis and quality of care for people with endometriosis.
Some sections are primarily symbolic (findings, title) and could raise expectations for immediate clinical or financial benefits that may not materialize quickly for patients.
Collecting and sharing sensitive health and demographic data for surveillance and reporting creates privacy risks and potential confidentiality breaches despite statutory protections.
Insurers, employer group plans, and state Medicaid programs may face new reporting and data-collection requirements that create compliance costs and administrative burdens.
Based on analysis of 3 sections of legislative text.
Establishes a federal endometriosis initiative funding research, surveillance, education, clinician guidance, and a National Academies disparities study with authorized FY2026–2030 funding.
Introduced December 11, 2025 by Nikema Williams · Last progress December 11, 2025
Establishes a federal endometriosis initiative that funds research and surveillance, analyzes barriers to care, runs public education, provides clinician guidance, and commissions a National Academies study on disparities. It authorizes multiyear funding for NIH-led research and HHS educational and clinician-outreach activities and requires reporting and data collection to better understand incidence, access, and outcomes.